Skip to main content

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 253A))

Abstract

It is generally accepted that many factors, such as hypertension, vascular disease, renal calculi and infection, may contribute to renal disease in patients with gout. However, these are usually regarded as secondary phenomena which are often superimposed on a primary nephropathy. Most studies of the gouty kidney, however, have found evidence of a primary nephropathy with deposits of urate and uric acid crystals (1, 2, 3); Talbott and Terplan (4), in a study of almost two hundred kidneys, concluded that “the only distinct pathological feature of the gouty kidney is the presence of urate crystals”. Crystallographic studies indicated that these crystals were either acicular crystals of monosodium urate monohydrate (urate or MSUM) or deposits of uric acid (UA) (5). Subsequent studies of urinary urate over-excretion, either following chemotherapy of malignancy (6) or due to HPRT deficiency (7, 8), have established the importance of intratubular uric acid deposition in the development of an acute uric acid nephropathy. Interstitial micro-tophi containing urate crystals have also been demonstrated in gouty kidneys and there is suggestive evidence that these might develop not only due to local formation, but also by the passage of uric acid crystals through the lining epithelium of the distal nephron into the interstitial tissues. This has been demonstrated with other crystals in animals (9). Indeed, urate crystals have been demonstrated by electron microscopy within the tubular lining cells of patients with leukemia (10). Thus, there is support for the hypothesis that, at least in some cases, renal damage from uric acid begins by a reaction between intraluminal uric acid crystals and tubular lining cells of the distal nephron. For this reason, a study was planned of the reaction between cultured renal tubular cells and crystals of urate and uric acid.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. J.B. Brown and G.K. Mallory, Renal changes in gout, N Engl J Med 243: 325–329 (1950).

    Article  PubMed  CAS  Google Scholar 

  2. R. Bluestone, J. Waisman and J.R. Klinenberg, The gouty kidney, Seminars in Arthritis and Rheumatism 7: 97–113 (1977).

    Article  PubMed  CAS  Google Scholar 

  3. B.T. Emmerson, Gout, uric acid and renal disease, Med J Aust 1: 403–405 (1976).

    PubMed  CAS  Google Scholar 

  4. J.H. Talbot and K.L. Terplan, The kidney in gout, Medicine (Baltimore) 39: 405–462 (1960).

    Google Scholar 

  5. J.E. Seegmiller and P.D. Frazier, Biochemical considerations of the renal damage of gout, Ann Rheum Dis 25: 668–672 (1966).

    PubMed  CAS  Google Scholar 

  6. K.G. Barry, R.H. Hunter, T.E. Davis and W.H. Crosby, AMA Archives Int Med 111: 453–459 (1963).

    Google Scholar 

  7. B.T. Emmerson and P.G. Row, An evaluation of the pathogenesis of the gouty kidney, Kidney Int 8: 65–71 (1975).

    Article  PubMed  CAS  Google Scholar 

  8. J.A. Batch, R.P. Riek, R.B. Gordon, J.R. Burke and B.T. Emmerson, Renal failure in infancy due to urate over-production, Aust NZ J Med 14: 852–854 (1984).

    Article  CAS  Google Scholar 

  9. D.A. Farebrother, P. Hatfield, et al, Experimental crystal nephropathy (one year study in the pig), Clinical Nephrology 4: 243 (1975).

    Google Scholar 

  10. Y.S. Kanwar and J.R. Manaligod, Leukemic urate nephropathy, Arch Pathol 99: 467–72 (1975).

    PubMed  CAS  Google Scholar 

  11. M.J. Rindler, L.M. Chuman, L. Shaffer and M.H. Saier Jr, Retention of differentiated properties in an established dog kidney epithelial cell line (MDCK), J Cell Biol 81: 635–648 (1979).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Press, New York

About this chapter

Cite this chapter

Emmerson, B.T., Axelsen, R., Cross, M. (1989). A Model of Gout Nephropathy. In: Mikanagi, K., Nishioka, K., Kelley, W.N. (eds) Purine and Pyrimidine Metabolism in Man VI. Advances in Experimental Medicine and Biology, vol 253A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5673-8_33

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5673-8_33

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5675-2

  • Online ISBN: 978-1-4684-5673-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics